Central and peripheral role of the nociceptin/orphaninFQ system on normal and disturbed colonic motor function and faecal pellet output in the rat

Neurogastroenterology and Motility

Volumn 20, Issue 8, 2008, Pages 939-948

  Broccardo, M ^a   Agostini, S ^a   Petrella, C ^a   Guerrini, R ^b   Improta, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Castor oil diarrhoea; Colonic propulsion; Corticotrophin release factor; Faecal pellet output; Nociceptin orphanin FQ analogues; Restraint stress

Indexed keywords

CASTOR OIL; CORTICOTROPIN RELEASING FACTOR; NOCICEPTIN; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON MOTILITY; CONTROLLED STUDY; DIARRHEA; EXPERIMENTAL RAT; FECES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT FUNCTION; IMMOBILIZATION STRESS; INTESTINAL DYSMOTILITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANIMALS; CASTOR OIL; CATHARTICS; COLON; CORTICOTROPIN-RELEASING HORMONE; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; MALE; OPIOID PEPTIDES; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; VASODILATOR AGENTS;

EID: 47649111176     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01120.x     Document Type: Article

References (51)

1. Meunier JC, Mollereau C, Toll L, et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995 377 : 532 5.
2. Bunzow JR, Saez C, Mortrud M, et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett 1994 347 : 284 8.
3. Calò G, Guerrini R, Rizzi A, Salvadori S, Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol 2000 129 : 1261 83.
4. Mollereau C, Mouledous L. Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 2000 21 : 907 17.
5. Yazdani A, Takahashi T, Bagnol D. Functional significance of a newly discovered neuropeptide, orphanin FQ, in rat gastrointestinal motility. Gastroenterology 1999 116 : 108 17.
6. Mitsuma T, Rhue N, Kayama M. Distribution of orphanin FQ in rat: an immunohistochemical study. Med Sci Res 1998 26 : 403 5.
7. Anton B, Fein J, To T, Silberstein L, Evans CL. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J Comp Neurol 1996 368 : 229 51.
8. Neal CR, Jr., Mansour A, Reinsheid R. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with 125I-(14Tyr)-orphaninFQ binding. J Comp Neurol 1999 412 : 563 605.
9. Florin S, Meunier JC, Costentin J. Autoradiographic localization of [H3]nociceptin binding sites in the rat brain. Brain Res 2000 880 : 11 6.
10. Sim-Selley LJ, Vogt LJ, Childers SR, Vogt BA. Distribution of ORL-1 receptor binding and receptor-activated G-proteins in rat forebrain and their experimental localization in anterior cingulate cortex. Neuropharmacology 2003 45 : 220 30.
11. Fox D, Burks TF. Roles of central and peripheral mu, delta and kappa receptors in the mediation of gastric motor and secretory effects in the rat. J Pharmacol Exp Ther 1988 244 : 456 62.
12. 2 opioid receptor agonists on gastric functions in the rat. Neuropharmacology 1994 33 : 977 81.
13. Osinski MA, Brown DR. Orphanin FQ/nociceptin: a novel neuromodulator of gastrointestinal function? Peptides 2000 21 : 999 1005.
14. Osinski MA, Bass P, Gaumnitz EA. Peripheral and central actions of Orphanin FQ (Nociceptin) on murine colon. Am J Physiol 1999 193 : G125 31.
15. Menzies JRW, Glen T, Davies MRP, Paterson SJ, Corbett AD. In vitro agonist effects of nociceptin and (Phe1 (CH2-NH)Gly2) nociceptin(1-13)NH2 in the mouse and rat colon and mouse vas deferens. Eur J Pharmacol 1999 385 : 217 23.
16. Takahashi T, Bagnol D, Schneider D, et al. Orphanin FQ causes contractions via inhibiting purinergic pathway in the rat colon. Gastroenterology 2000 119 : 1054 63.
17. Tada H, Nakagawa K, Yamamura T, Takahashi T. Antagonistic effects of CompB on orphaninFQ-induced colonic contractions in rats. Eur J Pharmacol 2002 454 : 53 8.
18. Li HY, Yan X, Xue QL, et al. Effects of nociceptin/orphaninFQ on rats with cathartic colon. World Gastroenterol 2007 13 : 141 5.
19. Menzies JRW, Corbett AD. Nociceptin inhibits tonic nitric oxide release in the mouse isolated proximal colon. Eur J Pharmacol 2000 388 : 183 6.
20. Taniguchi H, Yomota E, Nogi K, Onoda Y, Ikezawa K. The effect of nociceptin, an endogenous ligand for the ORL1 receptor, on rat colonic contraction and transit. Eur J Pharmacol 1998 353 : 265 71.
21. Takahashi T, Mizuta Y, Owyang C. OrphaninFQ but not dynorphin A, accelerates colonic transit in rats. Gastroenterology 2000 119 : 71 9.
22. Broccardo M, Guerrini R, Petrella C, Improta G. Gastrointestinal effects of i.c.v. injected nociceptin/orphaninFQ in rats. Peptides 2004 25 : 1013 20.
23. Broccardo M, Linari G, Guerrini R, Agostini S, Petrella C, Improta G. The effects of (Arg14, Lys15)nociceptin/orphaninFQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions. Peptides 2005 26 : 1590 7.
24. Arduin M, Spagnolo B, Calo' G, et al. Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha-alpha-dialkylated amino acids. Bioorg Med Chem 2007 15 : 4434 43.
25. Rizzi A, Spagnolo B, Wainford RD, et al. In vitro and in vivo studies on UFP-112, a novel potent and selective peptide agonist selective for the nociceptin/orphanin FQ receptor. Peptides 2007 28 : 1240 51.
26. Mc Donald J, Calò G, Guerrini R, Lambert DG. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radiologand and GTPg 35S binding studies. N S Arch Pharmacol 2003 367 : 183 7.
27. Calò G, Guerrini R, Rizzi A, et al. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. CNS Drug Rev 2005 11 : 97 112.
28. Broccardo M, Petrella C, Agostini S, Morini G, Polidori C, Improta G. The gastric effects of UFP 112, a new NOP receptor agonist, in physiological and pathological conditions. Peptides 2007 28 : 1974 81.
29. Raffa RB, Mathiasen JR, Jacoby HI. Colonic bead expulsion time in normal and mu-opioid deficient mice following central administration of mu- and delta-opiod agonists. Life Sci 1987 41 : 2229 34.
30. Niemegeers CJE, Awouters F, Janssen PAJ. The castor oil test in rats: an in vivo method to evaluate antipropulsive and antisecretory activity of antidiarrheals? Drug Dev Res 1984 4 : 223 7.
31. Martinez V, Tachè Y. Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats. Brain Research 2001 893 : 29 35.
32. Maillot C, Million M, Wei JY, Gauthier A, Tachè Y. Peripheral CRF and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology 2000 119 : 1569 79.
33. Mizuta Y, Takahashi T, Owyang C. Nitrergic regulation of colonic transit in rats. Am J Physiol 1999 277 : G275 9.
34. Nagano M, Ishimizu Y, Saitoh S, Okada H, Fukuda H. The defecation reflex in rats: fundamental properties and the reflex center. Auton Neurosci 2004 111 : 48 56.
35. Million M, Wang L, Martinez V, Tachè Y. Differential Fos expression in the paraventricular nucleus of the hypothalamus, sacral parasympathetic nucleus and colonic motor response to water avoidance stress in Fischer and Lewis rats. Brain Res 2000 877 : 345 53.
36. Tachè Y, Perdue MH. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 2004 1 : 137 42.
37. Baronic FC, Deegan JF, Price WJ, Fowler PJ, Fondacaro JD, Ormsbee HS. Cold-restraint stress increase rat fecal pellet output and colonic transit. Am J Physiol 1990 258 : G329 37.
38. Williams CL, Villar RG, Peterson JM, Burks TF. Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. Gastroenterology 1988 94 : 611 21.
39. Miyata K, Kamato T, Nishida A, et al. Role of the serotonin 3 receptor in stress-induced defecation. J Pharmacol Exp Ther 1992 261 : 297 303.
40. Menzies JRW, Glen T, Davies MRP, Paterson SJ, Corbett AD. In vitro agonist effects of nociceptin and (Phe1 (CH2-NH)Gly2) nociceptin(1-13)NH2 in the mouse and rat colon and mouse vas deferens. Eur J Pharmacol 1999 385 : 217 23.
41. Devine DP, Hoversten MT, Ueda Y, Akil H. Nociceptin/orphanin FQ content is decreased in Forebrain neurones during acute stress. J Neuroendocrinology 2003 15 : 69 74.
42. Leggett JD, Jessop DS, Fulford AJ. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm. Neuroscience 2007 147 : 757 64.
43. Tachè Y, Martinez V, Million M, Maillot C. Role of corticotrophin releasing factor receptor subtype I in stress-related functional colonic alterations: implications in irritable bowel syndrome. Eur J Surg 2002 168 : 16 22.
44. Martinez V, Tachè Y. Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats. Brain Res 2001 893 : 29 35.
45. Nakade Y, Fukuda H, Iwa M, Pappas T, Takahashi T. Restraint stress-induced acceleration of colonic transit is mediated via a central CRF and intraluminal 5HT3 receptors in conscious rats. Gastroenterology 2005 128 : A115 21.
46. Tachè Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotrophin-releasing factor receptors. Am J Physiol 2001 280 : G173 7.
47. Gavioli EC, Calo' G. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. N S Arch Pharmacol 2006 372 : 319 30.
48. Koster A, Montkowski A, Schulz S, et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci USA 1999 96 : 10444 9.
49. Blakley GG, Pohorecky LA, Benjamin D. Behavioral and endocrine changes following antisense oligonucleotide-induced reduction in the rat NOP receptor. Psychopharmacology (Berl) 2004 171 : 421 8.
50. Jenck F, Moreau JL, Martin JR, et al. Orphanin FQ acts as an anxiolytic to attenuate behavioural responses to stress. Proc Natl Acad Sci USA 1997 94 : 14854 8.
51. Jenck F, Wichmann J, Dautzenberg FM, et al. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc Natl Acad Sci USA 2000 979 : 4938 43.